UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1334

2023

Volltextzugriff (PDF)

The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models

International journal of molecular sciences, 2021-02, Vol.22 (4), p.1877

2021

Volltextzugriff (PDF)

Novel SEC61G - EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (21), p.5860-5872

2017

Volltextzugriff (PDF)

Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?

PloS one, 2014-07, Vol.9 (7), p.e101623

2014

Volltextzugriff (PDF)

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array

Cancer research (Chicago, Ill.), 2006-12, Vol.66 (23), p.11172-11178

2006

Volltextzugriff (PDF)

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies

Cancer chemotherapy and pharmacology, 2003-08, Vol.52 (2), p.131-138

2003

Volltextzugriff (PDF)

The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism

Biochemical pharmacology, 2007-03, Vol.73 (5), p.643-655

2007

Volltextzugriff (PDF)

Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction

Journal of cellular physiology, 2019-05, Vol.234 (5), p.6820-6830

2019

Volltextzugriff (PDF)

Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells

Oncology reports, 2021-02, Vol.45 (2), p.752-763

2021

Volltextzugriff (PDF)

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft

Anti-cancer drugs, 2005-09, Vol.16 (8), p.811-815

2005

Volltextzugriff (PDF)

hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF

Pathology oncology research, 2021-04, Vol.27, p.612375-612375

2021

Volltextzugriff (PDF)

Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models

Neuro-oncology (Charlottesville, Va.), 2014-08, Vol.16 (8), p.1067-1077

2014

Volltextzugriff (PDF)

Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models

Neuro-oncology (Charlottesville, Va.), 2014-02, Vol.16 (8), p.1067-1077

2014

Volltextzugriff (PDF)

Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models

International journal of cancer, 2012-09, Vol.131 (5), p.E791-E803

2012

Volltextzugriff (PDF)

The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects

Biochemical pharmacology, 2012-07, Vol.84 (2), p.163-171

2012

Volltextzugriff (PDF)

Gender Effect in Experimental Models of Human Medulloblastoma: Does the Estrogen Receptor [beta] Signaling Play a Role?

PloS one, 2014-07, Vol.9 (7)

2014

Volltextzugriff (PDF)

Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models

Cancer chemotherapy and pharmacology, 2012-12, Vol.70 (6), p.811-822

2012

Volltextzugriff (PDF)

Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo

Neuro-oncology (Charlottesville, Va.), 2009-06, Vol.11 (3), p.250-259

2009

Volltextzugriff (PDF)

Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models

Investigational new drugs, 2012-08, Vol.30 (4), p.1319-1330

2012

Volltextzugriff (PDF)

Abstract C205: Persistent cell cycle perturbations and apoptosis mediate the antitumor activity of ST1968 in pediatric models

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.C205-C205

2011

Volltextzugriff (PDF)

Abstract C206: High antitumor complete response rate to Namitecan (ST1968) in preclinical model of pediatric sarcomas

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.C206-C206

2011

Volltextzugriff (PDF)

Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (18), p.5902-5908

2003

Volltextzugriff (PDF)

Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma

Translational oncology, 2010-10, Vol.3 (5), p.326-335

2010

Volltextzugriff (PDF)

Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models

International journal of cancer, 2007-03, Vol.120 (5), p.1141-1149

2007

Volltextzugriff (PDF)

Antitumor activity of imatinib mesylate in neuroblastoma xenografts

Cancer letters, 2005-10, Vol.228 (1), p.211-219

2005

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(37)
Animals
(27)
Humans
(26)
Mice
(24)
Oncology
(18)
Male
(17)
Biological And Medical Sciences
(14)
Cell Line, Tumor
(13)
Mice, Nude
(12)
Pharmacology & Pharmacy
(10)
Medical Sciences
(9)
Pharmacology. Drug Treatments
(9)
Xenograft Model Antitumor Assays
(9)
Base Sequence
(8)
Female
(8)
Tumors
(8)
Antineoplastic Agents
(7)
Antineoplastic Agents - Pharmacology
(7)
Apoptosis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers

The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models

Novel SEC61G - EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens

Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array

Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies

The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism

Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction

Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells

Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft

hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF

Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models

Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models

Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models

The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects

Gender Effect in Experimental Models of Human Medulloblastoma: Does the Estrogen Receptor [beta] Signaling Play a Role?

Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models

Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo

Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models

Abstract C205: Persistent cell cycle perturbations and apoptosis mediate the antitumor activity of ST1968 in pediatric models

Abstract C206: High antitumor complete response rate to Namitecan (ST1968) in preclinical model of pediatric sarcomas

Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat

Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma

Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models

Antitumor activity of imatinib mesylate in neuroblastoma xenografts

Suchergebnisse filtern